4.7 Article

Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins

期刊

JOURNAL OF CELL BIOLOGY
卷 178, 期 5, 页码 733-740

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200702147

关键词

-

资金

  1. NCRR NIH HHS [S10 RR021228, S10 RR017980, S10-RR021228, S10-RR017980] Funding Source: Medline
  2. NICHD NIH HHS [T32 HD007104, T32-HD007104] Funding Source: Medline
  3. NIGMS NIH HHS [R01-GM53034, R01 GM053034] Funding Source: Medline
  4. NINDS NIH HHS [R01 NS041617, R01-NS41617] Funding Source: Medline
  5. Wellcome Trust Funding Source: Medline

向作者/读者索取更多资源

Small nuclear ribonucleoproteins (snRNPs) are core components of the spliceosome. The U1, U2, U4, and U5 snRNPs each contain a common set of seven Sm proteins. Three of these Sm proteins are posttranslationally modified to contain symmetric dimethylarginine (sDMA) residues within their C-terminal tails. However, the precise function of this modification in the snRNP biogenesis pathway is unclear. Several lines of evidence suggests that the methyltransferase protein arginine methyltransferase 5 (PRMT5) is responsible for sDMA modification of Sm proteins. We found that in human cells, PRMT5 and a newly discovered type 11 methyltralferase, PRMT7, are each required for Sm protein sDMA modification. Furthermore, we show that the two enzymes function nonredundantly in Sm protein methylation. Lastly, we provide in vivo evidence demonstrating that Sm protein sDMA modification is required for snRNP biogenesis in human cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据